Keywords
How to Cite
Abstract
The purpose - to carry out comparison of the cumulative morbidity on the lymphoid and myeloid leukemia on relatively clean and contaminated regions of the Cherkassy region for 2001 and 2014.
Materials and methods. The incidence was determined in regions A (relatively clean), B (radioactive contaminated), C (chemically contaminated) and D (radioactive and chemical contaminated) per 100 thousand population, which was registered during the All-Ukrainian census conducted in 2001, and in 2014 according to the published data of the State Statistical Service of Ukraine.
Results. In 2001, in the radioactive contaminated region of Cherkassy oblast, there was a 2.46-fold (p = 0.024) higher incidence of myeloid leukemias alone (5.30; 3.03-8.33 vs. 2.15; 0.66-3.64 per 100 thousand population, respectively). Instead, in the area contaminated with chemical factors, the prevalence of lymphoid (acute and chronic) was determined (7.12; 1.84 - 12.39 vs. 2.69; 1.02 - 4.35 per 100 thousand population, respectively) and myeloid (6.10; 1.22 - 10.99 vs. 2.15; 0.66 - 3.64 per 100 thousand population, respectively) leukemia, compared with relatively clean regions. According to 2001 data, who living in a chemical contaminated region, the risk of cumulative morbidity for acute and chronic lymphoid and myeloid leukemias is 3.30 (p = 0.014) and 2.83 (p = 0.043), respectively.
In 2014, no increase in the level of cumulative incidence of these hematological neoplasms was detected between the clean and contaminated regions of Cherkassy oblast.
Conclusions. It was proved that the radiation factor in 2001 increased the probability of growth the cumulative incidence only for myeloid leukemias, and chemical contamination - for both myeloid and lymphoid leukemias. In 2014, there was no increase in the level of cumulative incidence of certain hematological diseases between clean and contaminated regions of Cherkasy oblast.
References
Behjati, S., Gundem, G., Wedge, D. C., Roberts, N. D., Tarpey, P. S., Cooke, S. L., et al. (2016). J. Mutational signatures of ionizingradiationin second malignancies. NatCommun, Sep,7, 12605.
Davidson, P. R., Sherborne, A. L., Taylor, B., Nakamura, A. O., Nakamura, J. L. (2017). A pooled mutational analysisid entifiesionizingradiation-associated mutational signatures conserved between mousean dhuman malignancies. SciRep., 7(1), 7645.
Filippini, T., Hatch, E. E., Rothman, K. J., Heck, J. E., Park, A. S., Crippa, A., et al. (2019). Association between Outdoor Air Pollution and Childhood Leukemia: A Systematic Review and Dose-Response Meta-Analysis. Environ Health Perspect, Apr, 127(4), 46002.
Lin, C. K., Hsu, Y. T., Brown, K. D., Pokharel, B., Wei, Y., Chen, S. T. (2019). Residential exposure to petrochemical industrial complexes and the risk of leukemia: A systematic review and exposure-response meta-analysis. Environ Pollut., Nov 22, 113476. doi: 10.1016/j.envpol.2019.113476.
Preston, D.L.1, Kusumi, S., Tomonaga, M., Izumi, S., Ron, E, Kuramoto, A., et al. (1994). Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res., Feb, 137 (2), 68-97.
Romanenko, A. Y., Finch, S. C., Hatch, M., Lubin, J. H., Bebeshko, V. G., Bazyka, D. A, et al. (2008). The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: III. Radiation risks. Radiat Res., Dec, 170(6), 711-20.
Edwards, A., Voisin, P., Sorokine-Durm, I., Maznik, N., Vinnikov, V., Mikhalevich, L., et al. (2004). Biological estimates of dose inhabitants of Belarus and Ukraine following the Chernobyl accident. RadiatProt Dosimetry, 111(2), 211-9.
Delwail, V. Jais, J. P., Colonna, P., Andrieu, J. M. (2002). Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin’s disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. Br J Haematol., Jul, 118(1), 189-94.
Sill, H., Olipitz, W., Zebisch, A., Schulz, E., Wölfler, A. (2011). Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. Br J Pharmacol., Feb, 162(4),792-805.
Filippini, T., Hatch, E.E., Rothman, K.J., Heck, J.E., Park, A.S., Crippa, A., et al. (2019). Association between Outdoor Air Pollution and Childhood Leukemia: A Systematic Review and Dose-Response Meta-Analysis. Environ Health Perspect, Apr, 127(4), 46002.
Lin, C.K., Hsu, Y.T., Brown, K.D., Pokharel, B., Wei, Y., Chen, S.T. (2019). Residential exposure to petrochemical industrial complexes and the risk of leukemia: A systematic review and exposure-response meta-analysis. Environ Pollut., Nov, 22, 113476.
Poynter, J.N., Richardson, M., Roesler, M., Blair, C.K., Hirsch, B., Nguyen, P., et al. (2017). Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study. Int J Cancer., Jan, 140(1), 23-33.
Schnatter, A.R., Glass, D.C., Tang, G.,Irons, R.D., Rushton, L. (2012). Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J Natl Cancer Inst., Nov 21, 104(22), 1724-37.
Khalade, A., Jaakkola, M.S., Pukkala, E., Jaakkola, J.J. (2010). Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ Health., Jun, 9, 31.
Sielken, R.L.J., Valdez-Flores, C.A. (2015). Comprehensive review of occupational and general population cancer risk: 1,3-Butadiene exposure-response modeling for all leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, myeloid neoplasm and lymphoid neoplasm. ChemBiol Interact., Nov, 241, 50-8.
Li, K., Jing, Y., Yang, C., Liu, S., Zhao, Y., He, X., et al. (2014). Increased leukemia-associated gene expression in benzene-exposed workers. Sci Rep., Jul, 4, 5369.
Savitz, D.A., Andrews, K.W. (1997). Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind Med., Mar, 31(3), 287-95.
Natelson, E.A. (2007). Benzene-induced acute myeloid leukemia: A clinician’s perspective. Am. J. Hematol. 82, 826–30.
Costantini, A.S., Miligi, L., Vineis, P. (1998). An Italian multicenter case-control study on malignant neoplasms of the hematolymphopoietic system. Hypothesis and preliminary results on work-related risks. WILL (Working Group on Hematolymphopoietic Malignancies in Italy). Med Lav., Mar-Apr, 89(2), 164-76.
Murthy, S.L., Hitchcock, M.A., Endicott-Yazdani, T.R., Watson, J.T., Krause, J.R. (2017). Epstein-Barr virus-positive diffuse large B-cell lymphoma. Proc (BaylUniv Med Cent), 30(4), 443–444.
Ok, C.Y., Papathomas, T.G., Medeiros, L.J., Young, K.H. (2013). EBV-positive diffuse large B-cell lymphoma of the elderly. Blood.,Jul, 122(3), 328–340.
Swerdlow, S.H., Campo, E., Piler,i S.A., Harris, N.L., Stein, H., Siebert, R., et al. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood., May, 127(20), 2375–90.
Sahai, H., Kurshid, A. (1996). Statisticsinepidemiology: methodstechniquesandapplications. CRC Press, 352.
Matutes, E. (2018). The 2017 WHO updateonmature T- andnaturalkiller (NK) cellneoplasms. Int J LabHematol., May, 40 (1), 97-103.
vanVliet, C., Spagnolo, DV. (2020). T- and NK-celllymphoproliferativedisordersofthegastrointestinaltract: reviewandupdate. Pathology., Jan, 52(1), 128-41.
Hayes, R.B., Yin, S.N., Dosemeci, M., Li, G.L., Wacholder, S., Travis, L.B., et al. (1997 ) Benzene and the dose-related incidence of hematologic neoplasms in China. J Natl Can Inst, Jul, 89 (14), 1065–71.
Linet, M.S., Yin, S-N., Travis, L.B., et al. (1996). Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Environ Health Perspect Dec, 104 (6), 1353–63.
Ferreira, J.D., Couto, A.C., Pombo-de-Oliveira, M.S., Koifman, S. (2013). Brazilian Collaborative Study Group of Infant Acute Leukemia. In utero pesticide exposure and leukemia in Brazilian children < 2 years of age. Environ Health Perspect., Feb, 121(2), 269-75.
Mirmohammadi, S.J., Hashemi, A., Souzani, A., Dehghani, K., Atefi, A. Yazdi, Z.Z. (2010). Environmental Risk Factors for Acute Leukemia and Non-Hodgkin Lymphoma in Children. IranJPedHematolOncol., 1 (1), 1-3.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.